Approved, Cleared, Off-Label, Unapproved: Four Labels, Four Meanings

Written Sep 12, 2026Sources re-read Sep 24, 2026

General information — nobody clinical checked this

Nobody who works on this site holds a medical qualification, and it has never been past a clinician of any kind. Every grade on it is arithmetic on public documents, not a clinical opinion about anyone. Talk to a doctor or a dermatologist before starting, stopping or combining any treatment.

Diagnosis has to come first. Thyroid disease, low iron, alopecia areata, scarring alopecias, a medicine you are already taking and a heavy shed after illness or weight loss all thin hair, and none of them is pattern baldness — so none of them is fixed by a product bought for it. If you are not sure which you have, that is the first thing to ask, and what a dermatologist checks sets out what that appointment looks like.

Nothing on this page is a dose, a regimen or an instruction. How much of anything, how often and whether at all are decisions for a prescriber and the product’s own label.

Four words do most of the work in hair-loss marketing, and only one of them means a regulator looked at whether the thing works for hair. Approved, cleared, off-label and unapproved describe four different relationships with the FDA, and the distance between the first and the last is the distance between a randomised trial programme and a clinic's own enthusiasm.

Approved means a regulator examined this product for this purpose

Approval is the high bar. The FDA's own consumer explainer says new drugs and biological products must be FDA approved before they are marketed, and that the highest-risk devices generally require approval of a premarket application. For hair loss that list is very short: a topical sold over the counter, and a prescription tablet for men.

An approval is a decision about a specific product, for a specific use, in a specific group of people, with a label attached. The label is the interesting half. The prescription tablet's label names male pattern hair loss in men only, says it is not indicated for women, and carries the reported harms and the fact that stopping reverses the effect within twelve months. Approval never means safe; it means the harms were examined and written down.

Cleared means it looks enough like something already on sale

Clearance is a different route with a different question. The FDA's explainer describes moderate-risk devices marketed under 510(k) clearance — the manufacturer shows the device is substantially equivalent to one already on the market. Nobody has to demonstrate that the new device works; they have to demonstrate it is like something that was already allowed.

That is why FDA-cleared appears on laser caps, combs and helmets, and why a page that writes FDA-approved next to a device is making a claim the paperwork does not support. Clearance is not nothing: it is a real regulatory route with real requirements. It is simply not an approval, and the two words are used interchangeably in advertising precisely because most readers do not know the difference. On this site's index, that single word is why laser devices sit a tier below the approved medicines even though sham-controlled trials of them have been pooled.

Off-label means approved, but not for this

Off-label prescribing is legal, common and often reasonable: a doctor prescribes a medicine approved for one condition to treat another, based on judgement and evidence. Two entries in the index are here. Dutasteride is approved in the United States for prostate enlargement, not for hair; oral minoxidil is a blood-pressure medicine.

What changes off-label is who carries the unexamined risk. When a regulator approves a use, it has reviewed the trials, the labelling and the risk management for that use. Off-label, that review has not happened, and a prescriber who knows your history is standing in for it. This is exactly why nothing on this site tells anyone to take an off-label medicine: the decision is not a reader's to make from a web page, and not ours to suggest.

Unapproved covers three quite different things

The fourth category is the widest and the most abused, because it bundles together products that are outside approval by design with products that have simply never been examined.

Compounded medicines are mixed by a pharmacy for an individual prescription. The FDA says compounded drugs are not FDA approved. When the agency wrote to prescribers, compounders and consumers about compounded topical finasteride in April 2025, its first point was that there is no FDA-approved topical formulation of finasteride at all.
Dietary supplements are outside drug approval by statute. The FDA states plainly that it does not approve dietary supplements for safety and effectiveness, which is why no hair capsule can be FDA-approved, however the bottle is worded.
Cosmetics do not require FDA approval for the product or its labelling. A shampoo is free to make cosmetic claims about appearance; a claim to treat a condition would make it a drug, which is the line the wording on most hair-loss shampoos is carefully walking.

Below all of that sits the category the agency has actively warned about. The FDA has published a public safety notification on exosome products, says there are no FDA-approved exosome products, and has described serious adverse events in patients treated with them.

How to check a claim in about a minute

Ask what the word actually is. Approved, cleared and registered are not synonyms, and registered means almost nothing about efficacy.
Ask approved for what. A drug approved for one condition tells you nothing about a second one.
Ask who says so. A company press release announcing a filing is not a regulator's decision, and a planned submission date is not an approval date.
Ask what the label says, not what the landing page says. Labels are published and boring, which is why they are the most reliable thing in this market.
If the product is compounded, ask what is in it, who mixed it, and what the prescriber thinks the evidence for that combination is.

None of this tells you whether something will work. It tells you what has been examined, by whom, and for what question — which is half of what the index of hair-loss treatments grades, and the half most marketing hopes you will skip. The other half is trials, and the place where the two most often disagree is the pipeline: see what is actually in late-stage hair-loss trials.

Approved, cleared and the rest

Is FDA-cleared the same as FDA-approved?

No. Clearance is the 510(k) route for moderate-risk devices, where the maker shows the device is substantially equivalent to one already on the market. Approval is the higher bar the FDA applies to new drugs and the highest-risk devices, and it involves a decision about whether the product does what it claims for a defined use. A laser cap can be cleared; it cannot be approved for hair growth in the sense people assume when they read the word.

Can a supplement be FDA-approved for hair loss?

No, and no supplement is. The FDA says it does not approve dietary supplements for safety and effectiveness — they sit outside drug approval as a matter of law. A bottle that says FDA-registered facility is describing the factory, not the product, and a bottle claiming to treat a condition is claiming to be a drug.

Is off-label prescribing a bad sign?

Not in itself. It is legal, common and often well reasoned, and two of the treatments with the strongest pooled trial evidence for hair loss are prescribed off-label. What it means is that no regulator has reviewed that particular use, so the judgement rests entirely with the prescriber — which is why it is a conversation with a doctor rather than a purchase decision.

Why does compounded topical finasteride keep appearing if it is not approved?

Because compounding is legal and telehealth platforms market it. The FDA's April 2025 alert said there is no FDA-approved topical formulation of finasteride, that compounded products do not have FDA-approved labelling, and that it had received adverse-event reports naming effects that mostly persisted after people stopped. Trials of topical finasteride do exist, which is why it is graded in the middle of the index rather than at the bottom.

Everything here is graded on the same two questions in the index of hair-loss treatments, and the condition itself is set out in male pattern baldness. Information only, and nobody medically qualified has read it.